Opisthorchiasis Treatment Market to Grow with a CAGR of 6.21% through 2028
Growing research & development activities for the early diagnosis
and increasing demand for healthcare services & treatments is expected to
drive the Global Opisthorchiasis Treatment Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Opisthorchiasis
Treatment Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Opisthorchiasis Treatment
Market stood at USD
355.88 Million in 2022 and is anticipated to grow with a CAGR of 6.21% in the forecast
period, 2024-2028. Several factors are driving the growth of the Global
Opisthorchiasis Treatment Market. These include the increasing prevalence of
parasitic infections worldwide, growing awareness and understanding of the
disease's implications, and advancements in pharmacological research and drug
development.
Moreover, the efforts of government and
non-governmental organizations to control the disease and improve public health
are making significant contributions to market expansion. Additionally, the
expansion of healthcare infrastructure and increased healthcare spending in
developing regions create a favorable environment for market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Opisthorchiasis Treatment Market.”
The global Opisthorchiasis treatment market is
experiencing steady growth due to a rise in the prevalence of this disease,
particularly in Southeast Asia and Eastern Europe. Opisthorchiasis, caused by
liver fluke infections, is classified by the World Health Organization as one
of the neglected tropical diseases, indicating its higher occurrence in
impoverished areas with limited access to healthcare. This classification has
led to increased efforts in developing cost-effective treatment methods
worldwide, contributing to the overall expansion of the market.One of the key
trends in the Opisthorchiasis treatment market is the increased investment in
research and development for more effective and innovative drugs.
Pharmaceutical companies globally are engaged in a competitive race to develop
medications that not only eliminate the parasites but also facilitate fast
recovery and minimize side effects for the patients. Moreover, the involvement
of government bodies and non-governmental organizations (NGOs) in providing
healthcare amenities and raising awareness about this disease is further
catalyzing the growth of the market.
The Global Opisthorchiasis Treatment Market is
witnessing significant growth, driven by an increase in cases of
Opisthorchiasis, a parasitic disease prevalent in Southeast Asia and Eastern
Europe. This disease, caused by the Opisthorchis viverrini and Opisthorchis
felineus trematodes, affects millions worldwide, emphasizing the need for
effective treatment solutions. In recent years, the market has seen the
introduction of various novel drugs and therapies. Praziquantel, a medication
widely used in the treatment of multiple parasitic worm infections, leads as
the first-line treatment for Opisthorchiasis. The affordability and
effectiveness of Praziquantel have led to its dominance in the market. However,
the emergence of drug-resistant strains of parasites has necessitated the
development of alternative therapies, thus propelling the market forward. Another
key driver for the Opisthorchiasis Treatment Market is the increase in
healthcare expenditure worldwide, coupled with the growing awareness about this
disease. Public health initiatives and programs aimed at providing access to
necessary treatments in affected regions have contributed significantly to
market growth.
Moving forward, market players need to focus on
developing accessible, cost-effective treatments and improving diagnostic
techniques for Opisthorchiasis. Equally important is the implementation of mass
drug administration strategies and awareness campaigns in high-risk areas. Such
efforts will ensure not only the growth of the Opisthorchiasis Treatment Market
but also a significant reduction in the global burden of this parasitic
disease.However, despite the ongoing progress, the future outlook for the
global Opisthorchiasis treatment market remains promising. As research
continues to advance and healthcare provisions improve worldwide, the market is
expected to maintain its growth trajectory. Additionally, international
collaborations among different stakeholders for disease control are anticipated
to play a crucial role in augmenting the expansion of the market. The global
Opisthorchiasis treatment market is set on a steady growth path, driven by the
increasing prevalence of the disease, advancements in research and development,
and the improved provision of healthcare services. Nevertheless, to fully
unlock the market's potential, it is vital to raise awareness about
Opisthorchiasis and improve access to healthcare in affected areas.
The Global Opisthorchiasis Treatment Market is
segmented into type, diagnostic procedure, symptom, end user, regional
distribution, and company.
Based on end user, hospitals and clinics are currently
dominating the global opisthorchiasis treatment market primarily due to their
comprehensive healthcare infrastructure and accessibility to advanced
diagnostic and treatment options. These institutions are equipped with
state-of-the-art medical facilities, cutting-edge technologies, and a wide
range of specialized personnel including doctors, nurses, and laboratory
technicians. With their extensive expertise and experience in managing
opisthorchiasis, hospitals and clinics play a crucial role in effectively
diagnosing and treating this disease.Moreover, the high patient turnover in
hospitals and clinics ensures a continuous flow of cases, allowing healthcare
professionals to gain valuable insights and refine their treatment approaches.
This constant exposure to opisthorchiasis cases enables them to stay updated
with the latest research and advancements in the field, further enhancing their
ability to deliver optimal care to patients. In addition to their medical
prowess, hospitals and clinics also contribute significantly to public
awareness and education about opisthorchiasis. Through various outreach
programs, they educate the community about the risk factors, symptoms, and
preventive measures related to this parasitic infection. By raising awareness
and promoting early detection, hospitals and clinics play a vital role in
reducing the prevalence and impact of opisthorchiasis worldwide. Given the
multifaceted role they play, it is no surprise that hospitals and clinics
maintain a dominant position in the global opisthorchiasis treatment market. Their
comprehensive approach, combined with their commitment to excellence in patient
care, makes them the preferred choice for individuals seeking effective
diagnosis and management of opisthorchiasis.
Based on region, Asia Pacific segment is expected to
grow during the forecast period. The Asia Pacific region continues to
dominate the global opisthorchiasis treatment market due to a myriad of
contributing factors. This region, encompassing countries such as Thailand,
Laos, Cambodia, and Vietnam, experiences a high prevalence of opisthorchiasis,
necessitating the demand for effective treatment solutions. The presence of
numerous pharmaceutical companies dedicated to extensive research and
development of novel therapeutics further propels the market's growth in this
region. Moreover, the population in this area exhibits a relatively high level
of awareness about the disease, which in turn fosters the adoption of
appropriate treatment measures. With these combined factors, the Asia Pacific
region maintains its stronghold in the global opisthorchiasis treatment market.
Major companies operating in
Global Opisthorchiasis Treatment Market are:
- Cipla
Inc.
- Johnson
& Johnson
- Sun
Pharmaceutical Industries Ltd.
- Merck
KGaA
- Boehringer
Ingelheim International GmbH
- Pfizer
Inc.
- GlaxoSmithKline
plc
- F.
Hoffmann-La Roche Ltd
- AbbVie
Inc.
- Mankind
Pharma Limited
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global opisthorchiasis treatment market is poised
for significant growth, driven by increasing awareness of the disease,
advancements in healthcare technology, and the enhanced accessibility of
treatment options. With opisthorchiasis being prevalent in certain regions,
dedicated funding and research are being channeled to develop more effective
remedies. Emerging markets are expected to contribute substantially to the
market's expansion due to improving healthcare infrastructures. In the future,
the market may also benefit from personalized treatment plans, leveraging
advancements in genomics and precision medicine.,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Opisthorchiasis Treatment Market Segmented By Type (Medications
{Antibiotics, Anthelmintics, Others} v/s Surgery), By Diagnostic Procedure
(Cholangiography, MRI, Ultrasonography, CT scan, Others), By Symptom (Jaundice,
Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others), By End User
(Hospitals & Clinics, Ambulatory Care Centers, Others), By
Region and Competition, Forecast
& Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Opisthorchiasis Treatment Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Opisthorchiasis
Treatment Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
www.techsciresearch.com